Gene Therapy Power Stock Develops Treatments for Alzheimer’s and More
The number of American 65 and up with Alzheimer’s will double by 2060. This biopharma Power Stock develops gene therapies for Alzheimer’s and other diseases. It rates an 87 on our system.